Peptide Atlas · Peptide

Mazdutide

Mazdutide is a dual agonist of the glucagon receptor and the glucagon-like peptide-1 receptor.

established

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Mazdutide' · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 167312357: Mazdutide, C207H317N45O65, 4476 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 2259884-03-0. · 2026-09-27 04:00 · somebody
fact added summary: Mazdutide is a dual agonist of the glucagon receptor and the glucagon-like peptide-1 receptor. · 2026-09-27 04:00 · somebody
fact added history: It received its first approval in China in June 2025 for long-term weight management in adults with obesity or overweigh · 2026-09-27 04:00 · somebody
fact added history: In a phase 3 trial of 610 Chinese adults with overweight or obesity, body weight fell by about 10% and 12.5% on the two · 2026-09-27 04:00 · somebody
citation added pmid 41028652 cited as established: First approval (China, 2025) · 2026-09-27 04:00 · somebody
citation added pmid 40421736 cited as established: Phase 3 GLORY-1 trial in Chinese adults with obesity or overweight · 2026-09-27 04:00 · somebody

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.